Strategic Diagnostics Inc. 

(Public, NASDAQ:SDIX)   Watch this stock   
Find more results for SDIX
Oct 29, 2009
Q3 2009 Conference Call
Oct 29, 2009
Q3 2009 Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -10.71% -57.11%
Operating margin -10.42% -27.35%
EBITD margin - -22.29%
Return on average assets -12.11% -46.82%
Return on average equity -14.23% -54.11%
Employees 166 -

Address

111 Pencader Drive
Newark, DE 19702
United States - Map
+1-302-4566789 (Phone)
+1-302-4566770 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Strategic Diagnostics Inc. discussions

  View all discussions »

Description

Strategic Diagnostics Inc. (SDI) is a biotechnology company that develops, manufactures and markets antibody products and analytical test kits for a range of food, water, agricultural, industrial, environmental and scientific applications. The Company generates revenues through two business units: Life Sciences and Industrial BioDetection Tests. Its Life Sciences portfolio includes products and custom services that supply critical reagents used across the Life Science research and development markets. SDI’s Genomic Antibody Technology (GAT) is used in proteomic research, disease understanding and drug/biomarker discovery among academic, biotech, in-vitro diagnostic and pharmaceutical customers. The Company’s Industrial BioDetection portfolio includes immunoassays, which represent advanced technology detection of food pathogens, as well as water and soil contaminants. SDI’s RapidChek and SELECT kits are used for the detection of pathogens.

Officers and directors

Francis M. DiNuzzo
President, Chief Executive Officer
Age: 53
Bio & Compensation - Reuters
Kevin J. Bratton
Chief Financial Officer, Vice President - Finance
Age: 58
Bio & Compensation - Reuters
James W. Stave Ph.D.
Vice President - Research & Development, Chief Scientific Officer
Age: 54
Bio & Compensation - Reuters
Deborah Day Barbara
Vice President - Business Development
Bio & Compensation - Reuters
Stanley A. Fronczkowski
Corporate Secretary
Age: 57
Bio & Compensation - Reuters
Stephen L. Waechter
Director
Age: 59
Bio & Compensation - Reuters
Clifford L. Spiro
Director
Age: 54
Bio & Compensation - Reuters
C. Geoffrey Davis Ph.D.
Director
Age: 58
Bio & Compensation - Reuters
Steven R. Becker
Director
Age: 42
Bio & Compensation - Reuters
Richard Van den Broek
Director
Age: 43
Bio & Compensation - Reuters